All News
Filter News
Found 698 articles
-
NuProbe Technology Enables Accurate Quantitation of Mutations Below 0.01% VAF using Low-Depth Sequencing
10/21/2021
NuProbe scientists and collaborators recently announced research demonstrating the accurate quantitation of somatic mutations below 0.01% variant allele frequency (VAF).
-
Inspira Technologies Selects GlobalLogic for Software Development of its Early Extracorporeal Respiratory Support System that Functions as an "Artificial Lung"
10/13/2021
GlobalLogic Inc. , a Hitachi Group Company and leader in Digital Engineering, today announced that it has been selected by Inspira Technologies to develop an algorithm-enhanced digital platform powering the ART device
-
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
10/12/2021
Johnson & Johnson announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, will retire from the Company effective December 31, 2021.
-
HotSpot Therapeutics to Present at the Solebury Trout /BMO Fall Private Company Showcase
10/12/2021
HotSpot Therapeutics, Inc announced today that the company management will present and host one-on-one meetings at the virtual Solebury Trout/BMO Fall Private Company Showcase 2021.
-
Breakthrough Discovery Spearheaded by Nicholas Bernthal, M.D., Prevents Infections Related to Orthopedic Implants
10/6/2021
Biomedical engineers and surgeons at UCLA and Duke University have developed an antibiotic coating that can be applied to orthopedic implants during surgery to eliminate the chance of an infection around the implant.
-
Laboratory Centrifuges Application in Pharmaceutical, Biotechnology, and Microbiology Researches to Rise by 1.2x Through 2031
9/29/2021
Fact.MR – A Market Research and Competitive Intelligence Provider: As per a recent study by market research and competitive intelligence provider Fact.MR, the global laboratory centrifuge market is poised to reach US$ 1.6 Bn in 2021.
-
Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021
9/28/2021
Thermo Fisher Scientific, the world leader in serving science, today announced that within booth #1322 inside the Atlanta World Congress Center it is showing its expanding portfolio of instruments, assays, controls and related technologies for increasing speed, performance and flexibility within clinical and research labs.
-
Here’s a look at a few of the industry expansions that have been announced so far this month.
-
September 24 is World Cancer Research Day, a time for patients, caregivers and companies on the forefront of cancer R&D to look back and look ahead.
-
During the past two years, fundraising and investment in biotechnology have reached record levels.
-
Zai Lab Limited calls itself a growing global biopharmaceutical company and is continuing to live up to that claim with its latest expansion announcement.
-
Vektor Medical's vMap™ Mapping System Reported as Feasible and Effective as Part of a Non-Invasive Workflow for Arrhythmia Management When Using Stereotactic Ablative Radiotherapy
9/9/2021
Vektor Medical, Inc., a private company founded to develop the next-generation in arrhythmia mapping systems, today announced the publication of results of a dual-site study involving its non-invasive vMap™ system during stereotactic ablative radiotherapy (SAbR), in the peer-reviewed journal, Heart Rhythm O2.
-
Cancer Tissue Diagnostics Market Report: SWOT Analysis and Insights for Business Planning
9/8/2021
Timely diagnosis and treatment of cancer has become increasingly crucial for reducing the prevalence of the disease, and in particular preventing cancer-related deaths.
-
Inaugural ARUP Laboratories Symposium Offers Strategies to Help Lab Leaders Advance Their Labs' Value in Their Healthcare Systems
8/18/2021
Northwell Health president and CEO Michael J. Dowling, MSW, will be the keynote speaker for ARUP Laboratories' inaugural Lab Leadership Symposium, "Creating Connections: Advancing Your Lab's Value in the Healthcare System," which will be held Thursday, October 21, 2021, via Zoom.
-
Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates
8/9/2021
Ziopharm Oncology, Inc., provided corporate updates for the second quarter of 2021, ended June 30, 2021.
-
AIkido Provides Update on Use of Machine Learning in Drug Development Program
8/6/2021
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of Medicine.
-
Biotech jobs are one of the most promising career paths for people who are into life sciences and those who dream of creating change in the world through developing breakthrough medicines and therapeutics.
-
Mirimus and Biogen, AavantiBio and Aldevron, Exscientia and GT Apeiron Therapeutics announced strategic partnerships this morning.
-
Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
7/21/2021
Mirimus, Inc. today announced a strategic collaboration with Biogen Inc. (NASDAQ: BIIB) focused on the development of RNAi-based therapeutics targeting multiple, undisclosed neurological disease indications.
-
Frontier Medicines will support the continued development of the company’s chemoproteomics drug discovery program, including lead asset, an inhibitor of KRASG12C.